FdaApplication
NDA 021260
Identifiers
- fda_app_no: NDA021260
Properties
| Property | Value |
|---|---|
| applicant_name | KING PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2002-03-20 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVINZA | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AVINZA | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AVINZA | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AVINZA | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AVINZA | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AVINZA | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
6 products